National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure

被引：49

作者：

Tang, W. H. Wilson ^{[6
]}

Francis, Gary S. ^{[6
]}

Morrow, David A. ^{[5
]}

Newby, L. Kristin ^{[4
]}

Cannon, Christopher P. ^{[5
]}

Jesse, Robert L. ^{[3
]}

Storrow, Alan B. ^{[2
]}

Christenson, Robert H. ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

[2] Vanderbilt Univ, Nashville, TN USA

[3] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA

[4] Duke Univ, Med Ctr, Durham, NC 27706 USA

[5] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA

[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA

来源：

CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 4-5期

关键词：

D O I：

10.1016/j.clinbiochem.2007.07.002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：210 / 221

页数：12

共 148 条

[1] Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the maze procedure [J].

Albåge, A ;

Kennebäck, G ;

van der Linden, J ;

Berglund, H .

ANNALS OF THORACIC SURGERY, 2003, 75 (03) :790-795

[2] Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care [J].

Alehagen, U ;

Lindstedt, G ;

Eriksson, H ;

Dahlström, U .

CLINICAL CHEMISTRY, 2003, 49 (08) :1337-1346

[3] C-reactive protein as a predictor of improvement and readmission in heart failure [J].

Alonso-Martínez, JL ;

Llorente-Diez, B ;

Echegaray-Agara, M ;

Olaz-Preciado, F ;

Urbieta-Echezarreta, M ;

González-Arencibia, C .

EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :331-336

[4] Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) [J].

Anand, IS ;

Fisher, LD ;

Chiang, YT ;

Latini, R ;

Masson, S ;

Maggioni, AP ;

Glazer, RD ;

Tognoni, G ;

Cohn, JN .

CIRCULATION, 2003, 107 (09) :1278-1283

[5] Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study [J].

Anwaruddin, S ;

Lloyd-Jones, DM ;

Baggish, A ;

Chen, A ;

Krauser, D ;

Tung, R ;

Chae, C ;

Januzzi, JL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :91-97

[6]

Beck-da-Silva Luis, 2005, Congest Heart Fail, V11, P248, DOI 10.1111/j.1527-5299.2005.04239.x

[7] Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients [J].

Berdagué, P ;

Caffin, PY ;

Barazer, I ;

Vergnes, C ;

Sedighian, S ;

Letrillard, S ;

Pilossof, R ;

Goutorbe, F ;

Piot, C ;

Reny, JL .

AMERICAN HEART JOURNAL, 2006, 151 (03) :690-698

[8] B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].

Berger, R ;

Huelsman, M ;

Strecker, K ;

Bojic, A ;

Moser, P ;

Stanek, B ;

Pacher, R .

CIRCULATION, 2002, 105 (20) :2392-2397

[9] C-Reactive protein in acute myocardial infarction: Association with heart failure [J].

Berton, G ;

Cordiano, R ;

Palmieri, R ;

Pianca, S ;

Pagliara, V ;

Palatini, P .

AMERICAN HEART JOURNAL, 2003, 145 (06) :1094-+

[10]

BHALLA V, 2004, CONGEST HEART FAIL S, V1, P3

← 1 2 3 4 5 6 7 8 9 10 →